|
|
| |
| Some Brains Resist Alzheimer’s. Scientists May Finally Know Why. |
| This one stopped me cold. About 30 percent of older adults who develop the brain changes of Alzheimer’s disease never show a single symptom. Their brains have the plaques. They have the tangles. But they think clearly. They remember names. They live without confusion into their 80s and beyond. |
| Nobody could explain it. Until now. |
| A team at the Netherlands Institute for Neuroscience, led by Evgenia Salta, examined donated human brain tissue from three groups: healthy brains, brains with Alzheimer’s dementia, and brains that had Alzheimer’s pathology but belonged to people who stayed mentally sharp. That third group is the mystery. Scientists call their ability “cognitive resilience.” |
| Let me explain what they found. Deep in the brain’s memory center, there are rare, immature neurons—brain cells that haven’t fully grown up yet. Salta’s team found these cells in every group, even in brains over age 80. That alone is striking. But the real discovery was what these cells were doing. |
| |
In resilient brains, the immature neurons had switched on survival and protection programs. They showed lower signals for inflammation and cell death. In brains with dementia, those same cells had not activated those defenses. |
|
| Think of it like a garden. The disease is a drought hitting every plot equally. In some gardens, a handful of young plants release something that keeps the soil moist and the older plants alive. In other gardens, those same young plants just sit there. Same drought. Different outcomes. |
| Salta puts it plainly: the difference may not be how many immature neurons you have. It’s how they respond when the brain comes under attack. I could be wrong, of course—this is one piece of a large puzzle, and the team hasn’t proven exactly what these cells do. But the direction is clear. |
| I believe this shifts the entire conversation. Instead of only asking “What destroys the brain?” we should also be asking “What protects it?” I urge you to pay attention to this line of research. It may matter more than any drug in the pipeline. |
| Netherlands Institute for Neuroscience · October 27, 2026 |
|
|
|
|
| |
| The 10-Minute Morning Light Reset |
| Your brain runs on a clock. Not a metaphor—a real one. It’s called the suprachiasmatic nucleus, a tiny cluster of about 20,000 neurons sitting just above where your optic nerves cross. That cluster sets the timing for cortisol, melatonin, and body temperature. It shapes how well you think, sleep, and recover. |
| And the single strongest input to that clock is light. Specifically, bright outdoor light hitting your eyes in the first hour after waking. That light triggers a cortisol pulse—not the stress kind, but the “wake up and focus” kind. It also starts a countdown: roughly 14 to 16 hours later, melatonin rises and sleep pressure builds. |
| Without that morning signal, the clock drifts. Cortisol comes late. Melatonin comes late. You feel groggy in the morning and wide awake at midnight. Over months and years, that drift chips away at sleep quality—and sleep quality is tied directly to how well your brain clears waste at night. You see, the same glymphatic system we covered earlier this week depends on deep sleep. And deep sleep depends on a well-set clock. |
| The Protocol |
| When |
| Within the first hour of waking—before you check email, before coffee |
| Duration |
| 10 minutes outside on clear days, 20 minutes on cloudy days. Overcast skies still deliver far more light than any indoor lamp. |
| Rules |
| No sunglasses—the light needs to reach your retinas through your eyes, not your skin. Don’t stare at the sun. Just face the bright sky. A porch, a driveway, a short walk around the block—all count. Do it every day, even weekends. Consistency is what resets the clock. |
| |
| Most people notice better sleep within a week. Give it two full weeks before judging. And if you’re already sleeping well, this still helps—it anchors your cortisol timing, which sharpens morning focus. I urge you to try it this weekend. |
|
|
|
|
|
|
|
| Mayo Clinic Finds New Ways to Fight “Zombie Cells” in the Aging Brain |
| Seven new studies from Mayo Clinic’s Kogod Center on Aging map how senescent cells—old cells that stop dividing but refuse to die—drive brain inflammation and decline. The team tested senolytic drugs (compounds that kill these zombie cells), a natural compound found in tomatoes, and genetic techniques. In older mice, the treatments reduced brain inflammation and improved performance on thinking tasks. One study also identified a blood marker called IL-23R that could one day help doctors measure biological aging with a simple draw. The work is still in mice. But the target is clear: stop the zombie cells, and you may slow the damage. |
| Mayo Clinic / Nature journals · October 26, 2026 |
|
|
| Alcohol Turns the Brain’s Immune Cells Against It |
| For decades, scientists assumed alcohol damaged the brain by acting directly on neurons. A Cleveland Clinic team just showed that’s only part of the story. Within one hour of heavy drinking in mice, microglia—the brain’s resident immune cells—pulled back their patrol branches and started tearing apart the extracellular matrix. That’s the protein scaffolding that holds neurons in place and keeps their signals running. Strip it away, and you get the sedation, the motor sloppiness, and—after repeated binges—permanent cell death in the frontal cortex. The team confirmed the same damage pattern in post-mortem human brain tissue from people with severe alcohol use disorder. They also found a molecular switch called MyD88 that triggers the whole cascade. Block it, and the damage stopped—even at the same blood alcohol level. |
| Cleveland Clinic / Immunity · October 8, 2026 |
|
|
| Magnetic Brain Stimulation Slowed Alzheimer’s Progression 44% Over One Year |
| Sinaptica Therapeutics published results from a 52-week trial of 48 people with mild-to-moderate Alzheimer’s. Their device, called SinaptiStim, uses repetitive transcranial magnetic stimulation—painless magnetic pulses aimed at a specific brain region called the precuneus, which is part of the network hit earliest by Alzheimer’s. Each person’s treatment was calibrated to their own brain using imaging and electrical recordings. Over one year, the treated group declined 44 percent slower on the main clinical scale compared to the sham group. Daily living scores and cognitive test scores also favored the treated group. It’s a small trial, single site, and has no biomarker data yet. But a non-drug, non-invasive treatment slowing Alzheimer’s by nearly half in a year is a number worth watching. |
| Sinaptica Therapeutics / Alzheimer’s Research & Therapy · April 2025 |
|
|
|
|
| Should Men Over 55 Use Testosterone Therapy to Protect Their Brains? |
| Side A |
| Testosterone drops about 1 to 2 percent per year after age 30. By 60, many men are well below their younger baseline. Low testosterone is linked to brain fog, worse spatial memory, and slower processing speed in observational studies. Some clinicians argue that restoring levels to a healthy range protects hippocampal volume. It may also support myelin—the insulation around nerve fibers—that keeps signals moving fast. A growing number of men’s health doctors now prescribe testosterone replacement for cognitive complaints. The anecdotal reports of sharper thinking are common. |
| Side B |
| The largest controlled trial tells a different story. The Testosterone Trials enrolled 788 men aged 65 and older with low testosterone. After one year of treatment, sexual function improved. Walking distance improved. But memory and cognitive function did not. The TRAVERSE cardiovascular safety trial of over 5,000 men found no brain benefit either. And testosterone carries real risks: higher red blood cell counts that thicken blood, possible prostate concerns, and heart-safety questions still being tracked. The observational links between low testosterone and poor cognition may simply reflect that sicker, less active men tend to have both. |
|
|
